TD Asset Management’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.9M | Sell |
453,590
-357,583
| -44% | -$36.7M | 0.04% | 349 |
|
|
2025
Q4 | $86.1M | Sell |
811,173
-112,010
| -12% | -$13M | 0.07% | 214 |
|
|
2025
Q3 | $117M | Sell |
923,183
-102,669
| -10% | -$12.2M | 0.1% | 176 |
|
|
2025
Q2 | $126M | Sell |
1,025,852
-313,361
| -23% | -$35.8M | 0.11% | 164 |
|
|
2025
Q1 | $136M | Sell |
1,339,213
-183,696
| -12% | -$17.9M | 0.12% | 154 |
|
|
2024
Q4 | $141M | Sell |
1,522,909
-171,467
| -10% | -$16.8M | 0.12% | 156 |
|
|
2024
Q3 | $163M | Sell |
1,694,376
-242,224
| -13% | -$21.8M | 0.14% | 143 |
|
|
2024
Q2 | $166M | Sell |
1,936,600
-347,074
| -15% | -$29.1M | 0.15% | 137 |
|
|
2024
Q1 | $189M | Buy |
2,283,674
+314,488
| +16% | +$23M | 0.18% | 124 |
|
|
2023
Q4 | $131M | Buy |
1,969,186
+1,389,275
| +240% | +$90M | 0.13% | 148 |
|
|
2023
Q3 | $38.9M | Sell |
579,911
-37,847
| -6% | -$2.6M | 0.05% | 298 |
|
|
2023
Q2 | $41.8M | Buy |
617,758
+19,399
| +3% | +$1.22M | 0.05% | 301 |
|
|
2023
Q1 | $32.4M | Buy |
598,359
+98,757
| +20% | +$5.75M | 0.04% | 338 |
|
|
2022
Q4 | $29.9M | Buy |
499,602
+76,803
| +18% | +$4.18M | 0.04% | 351 |
|
|
2022
Q3 | $19.5M | Sell |
422,799
-2,858
| -0.7% | -$143K | 0.02% | 423 |
|
|
2022
Q2 | $19M | Buy |
425,657
+250,422
| +143% | +$12.8M | 0.02% | 443 |
|
|
2022
Q1 | $9.91M | Hold |
175,235
| – | – | 0.01% | 663 |
|
|
2021
Q4 | $9.1M | Buy |
175,235
+4,111
| +2% | +$212K | 0.01% | 701 |
|
|
2021
Q3 | $10.2M | Hold |
171,124
| – | – | 0.01% | 646 |
|
|
2021
Q2 | $11.3M | Sell |
171,124
-165,688
| -49% | -$11M | 0.01% | 618 |
|
|
2021
Q1 | $21.9M | Buy |
336,812
+72,704
| +28% | +$4.74M | 0.02% | 442 |
|
|
2020
Q4 | $17.4M | Sell |
264,108
-1,636
| -0.6% | -$96.2K | 0.02% | 460 |
|
|
2020
Q3 | $13.7M | Buy |
265,744
+8,128
| +3% | +$417K | 0.02% | 472 |
|
|
2020
Q2 | $12.7M | Sell |
257,616
-20,463
| -7% | -$1.1M | 0.02% | 456 |
|
|
2020
Q1 | $14.2M | Buy |
278,079
+100,032
| +56% | +$5.77M | 0.02% | 398 |
|
|
2019
Q4 | $9.81M | Buy |
178,047
+129,255
| +265% | +$7.01M | 0.01% | 559 |
|
|
2019
Q3 | $2.46M | Hold |
48,792
| – | – | ﹤0.01% | 862 |
|
|
2019
Q2 | $2.46M | Buy |
48,792
+2,717
| +6% | +$132K | ﹤0.01% | 867 |
|
|
2019
Q1 | $2.14M | Sell |
46,075
-3,478
| -7% | -$176K | ﹤0.01% | 889 |
|
|
2018
Q4 | $2.43M | Sell |
49,553
-70,599
| -59% | -$4.02M | ﹤0.01% | 865 |
|
|
2018
Q3 | $7.45M | Sell |
120,152
-11,313
| -9% | -$688K | 0.01% | 615 |
|
|
2018
Q2 | $7.08M | Sell |
131,465
-13,072
| -9% | -$653K | 0.01% | 602 |
|
|
2018
Q1 | $6.57M | Buy |
+144,537
| New | +$6.2M | 0.01% | 603 |
|
|
2017
Q4 | – | Sell |
-73,643
| Closed | -$2.71M | – | 1341 |
|
|
2017
Q3 | $2.71M | Buy |
73,643
+126
| +0.2% | +$4.49K | ﹤0.01% | 796 |
|
|
2017
Q2 | $2.83M | Hold |
73,517
| – | – | ﹤0.01% | 803 |
|
|
2017
Q1 | $2.5M | Sell |
73,517
-12,193
| -14% | -$400K | ﹤0.01% | 840 |
|
|
2016
Q4 | $2.81M | Buy |
+85,710
| New | +$2.78M | ﹤0.01% | 794 |
|
Other funds holding EHC
VPM
VCM
TD Asset Management's EHC Position: Q1 2026 in Review
TD Asset Management reduced its Encompass Health (EHC) stake by 44% in Q1 2026, selling an estimated $36.7M and leaving 453,590 shares worth $43.9M. The position accounts for 0.04% of the portfolio, ranked #349.
TD Asset Management first reported a position in EHC in Q4 2016 and has held it in 37 quarters since. The position peaked at $189M in Q1 2024. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- TD Asset Management held 453,590 shares of Encompass Health worth $43.9M as of Q1 2026.
- TD Asset Management sold 357,583 Encompass Health shares in Q1 2026, an estimated $36.7M.
- Encompass Health made up 0.04% of TD Asset Management's portfolio in Q1 2026, its #349 holding.
- TD Asset Management first reported a position in Encompass Health in Q4 2016 and has held it in 37 quarters since.
- TD Asset Management's Encompass Health position peaked at $189M in Q1 2024.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.